Publications by authors named "Birgit T Roge"

Claim this Profile
L
Long-term anti-SARS-CoV-2 antibody trajectories after neutralizing monoclonal antibody treatment.
Elizabeth S Munroe, Greg A Grandits, Robert C Hyzy, Hallie C Prescott, Thomas W Barrett

PLoS One· June 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Ceiling-mounted far-UVC fixtures reduce the surface bioburden in occupied clinical areas.
Emilie Hage Mogensen, Jacob Thyrsted Jensen, Søren Helbo Skaarup, Andreas Fløe Hvass, Cecilie Lynggaard Jeppesen

Infect Control Hosp Epidemiol· April 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Clinical characteristics and diagnostic accuracy of preliminary diagnoses in adults with infections in Danish emergency departments: a multicentre combined cross-sectional and diagnostic study.
Helene Skjøt-Arkil, Mariana B Cartuliares, Anne Heltborg, Morten Hjarnø Lorentzen, Mathias Amdi Hertz

BMJ Open· December 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Antiviral combination treatment of SARS-CoV-2 after repeated treatment failures of remdesivir monotherapy: A case report.
Anne Cathrine Bay, Michael R Clausen, Birgit Thorup Røge, Thomas V Sydenham, Kat Steinke

IDCases· November 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Combining cross-sectional survey and register data improved the estimate of hepatitis C prevalence among patients attending a psychiatric emergency department in Denmark.
Thomas Vemmelund Rose, Peer Brehm Christensen, Peter Hjorth, Lone Wulff Madsen, Janne Fuglsang Hansen

Infect Dis (Lond)· April 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
H
Hepatitis C screening and linkage to care with a mobile clinic in Southern Denmark.
Sandra Dröse, Anne Lindebo Holm Øvrehus, Dorte Kinggaard Holm, Birgit Thorup Røge, Peer Brehm Christensen

Int J Drug Policy· November 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Retrieval of patients with hepatitis C who were lost to follow-up in Southern Denmark.
Sandra Dröse, Janne Fuglsang Hansen, Birgit Thorup Røge, Anne Lindebo Holm Øvrehus, Peer Brehm Christensen

Infect Dis (Lond)· May 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
L
Long-Term Antibody Response against SARS-CoV-2 in Health Care Workers: Effectiveness of Homologous and Heterologous Regimens and Their Relation to Systemic Vaccine-Associated Symptoms.
Helene Kierkegaard, Birgit Thorup Røge, Amanda Nissen, Jonna Skov Madsen

Vaccines (Basel)· September 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A multi-level intervention to eliminate hepatitis C from the Region of Southern Denmark: the C-Free-South project.
Sandra Dröse, Anne Lindebo Holm Øvrehus, Dorte Kinggaard Holm, Lone Wulff Madsen, Belinda Klemmensen Mössner

BMC Infect Dis· March 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
F
Four Weeks Treatment with Glecaprevir/Pibrentasvir + Ribavirin-A Randomized Controlled Clinical Trial.
Lone W Madsen, Peer B Christensen, Janne F Hansen, Birgit T Røge, Dorte K Holm

Viruses· March 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
SARS-CoV-2 seroprevalence among 7950 healthcare workers in the Region of Southern Denmark.
Sebastian von Huth, Søren Thue Lillevang, Birgit Thorup Røge, Jonna Skov Madsen, Christian Backer Mogensen

Int J Infect Dis· November 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
G
Global evolutionary analysis of chronic hepatitis C patients revealed significant effect of baseline viral resistance, including novel non-target sites, for DAA-based treatment and retreatment outcome.
Ulrik Fahnøe, Martin S Pedersen, Christina Sølund, Anja Ernst, Henrik B Krarup

J Viral Hepat· February 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
L
Low incidence of HCC in chronic hepatitis C patients with pretreatment liver stiffness measurements below 17.5 kilopascal who achieve SVR following DAAs.
Jacob Søholm, Janne Fuglsang Hansen, Belinda Mössner, Birgit Thorup Røge, Alex Lauersen

PLoS One· January 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Direct acting antiviral treatment of chronic hepatitis C in Denmark: factors associated with and barriers to treatment initiation.
Christina Sølund, Sofie Hallager, Martin S Pedersen, Ulrik Fahnøe, Anja Ernst

Scand J Gastroenterol· November 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
O
Outcome and adverse events in patients with chronic hepatitis C treated with direct-acting antivirals: a clinical randomized study.
Christina Sølund, Ellen S Andersen, Belinda Mössner, Alex L Laursen, Birgit T Røge

Eur J Gastroenterol Hepatol· October 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
N
Nationwide experience of treatment with protease inhibitors in chronic hepatitis C patients in Denmark: identification of viral resistance mutations.
Christina Sølund, Henrik Krarup, Santseharay Ramirez, Peter Thielsen, Birgit T Røge

PLoS One· September 2015

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Impact of injecting drug use on response to highly active antiretroviral treatment in HIV-1-infected patients: a nationwide population-based cohort study.
Mette Vang Larsen, Lars Haukali Omland, Jan Gerstoft, Birgit T Røge, Carsten Schade Larsen

Scand J Infect Dis· December 2010

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Severe Actinomyces israelii infection involving the entire spinal cord.
Shahin Gaïni, Birgit Thorup Røge, Court Pedersen, Svend Stenvang Pedersen, Anne-Sofie Brenøe

Scand J Infect Dis· May 2006

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
F
Foscarnet used in salvage therapy of HIV-1 patients harbouring multiple nucleotide excision mutations.
Sofie Mathiesen, Birgit T Roge, Nina Weis, Jens D Lundgren, Niels Obel

AIDS· April 2004

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
N
Natural history of hyperlactataemia in human immunodeficiency virus-1-infected patients during highly active antiretroviral therapy.
Tuan K Huynh, Hans R Lüttichau, Birgit T Roge, Jan Gerstoft

Scand J Infect Dis· May 2003

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
K
K65R with and without S68: a new resistance profile in vivo detected in most patients failing abacavir, didanosine and stavudine.
Birgit T Røge, Terese L Katzenstein, Niels Obel, Henrik Nielsen, Ole Kirk

Antivir Ther· April 2003

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Skeletal muscle mitochondrial function and exercise capacity in HIV-infected patients with lipodystrophy and elevated p-lactate levels.
Birgit T Røge, José A L Calbet, Kirsten Møller, Henrik Ullum, Helle W Hendel

AIDS· May 2002

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis